← Leaderboards
Christine Fillmore Brainson
University Of Kentucky
$3,775,692
Attributed
$3,775,692
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $698.1K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,775,692 · 3
By mechanism
R01$3,293,630 · 2
K22$482,062 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Kentucky
Same institution · by research overlap
- Ramon C. Sun$5,151,131
- Yasminka Aleksandra Jakubek Swartzlander$540,502
- Qiou Wei$2,427,502
- Lisa A Cassis$35,386,044
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsEpigenetic ProcessEzh2 GeneResponseComplexOrganoidsPhenotypeTranscriptome SequencingChip-SeqLungPharmaceutical PreparationsGenesDrug CombinationsCancer EtiologyImmuneMouse ModelGene ExpressionMalignant Neoplasm Of LungNeoplastic CellCell TypeCessation Of LifeCancer PatientLung NeoplasmsGenetic Transcription
Grant awards (12)
Targeting Lung Fibrosis Using Epigenetic Therapy$698,070
R01 · FY2025 · HL · contact PI
Targeting Lung Fibrosis Using Epigenetic Therapy$698,070
R01 · FY2024 · HL · contact PI
Targeting epigenetic heterogeneity to improve lung cancer immunotherapy response$342,988
R01 · FY2023 · CA · contact PI
Targeting Epigenetic Heterogeneity to Improve Lung Cancer Immunotherapy Response$77,275
R01 · FY2023 · CA · contact PI
Targeting Epigenetic Heterogeneity to Improve Lung Cancer Immunotherapy Response$77,275
R01 · FY2023 · CA · contact PI
Targeting epigenetic heterogeneity to improve lung cancer immunotherapy response$349,988
R01 · FY2022 · CA · contact PI
Targeting epigenetic heterogeneity to improve lung cancer immunotherapy response$349,988
R01 · FY2021 · CA · contact PI
Targeting epigenetic heterogeneity to improve lung cancer immunotherapy response$349,988
R01 · FY2020 · CA · contact PI
Targeting epigenetic heterogeneity to improve lung cancer immunotherapy response$349,988
R01 · FY2019 · CA · contact PI
Defining epigenetic vulnerabilities of subtype-specific lung cancers$163,736
K22 · FY2018 · CA · contact PI
Defining epigenetic vulnerabilities of subtype-specific lung cancers$163,736
K22 · FY2017 · CA · contact PI
Defining epigenetic vulnerabilities of subtype-specific lung cancers$154,590
K22 · FY2016 · CA · contact PI